Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Werner syndrome helicase is a selective vulnerability of microsatellite instability-high tumor cells.

Lieb S, Blaha-Ostermann S, Kamper E, Rippka J, Schwarz C, Ehrenhöfer-Wölfer K, Schlattl A, Wernitznig A, Lipp JJ, Nagasaka K, van der Lelij P, Bader G, Koi M, Goel A, Neumüller RA, Peters JM, Kraut N, Pearson MA, Petronczki M, Wöhrle S.

Elife. 2019 Mar 25;8. pii: e43333. doi: 10.7554/eLife.43333.

2.

Fusobacterium nucleatum Infection in Colorectal Cancer: Linking Inflammation, DNA Mismatch Repair and Genetic and Epigenetic Alterations.

Koi M, Okita Y, Carethers JM.

J Anus Rectum Colon. 2018;2(2):37-46. doi: 10.23922/jarc.2017-055. Epub 2018 Apr 25.

3.

Inflammation-associated microsatellite alterations: Mechanisms and significance in the prognosis of patients with colorectal cancer.

Koi M, Tseng-Rogenski SS, Carethers JM.

World J Gastrointest Oncol. 2018 Jan 15;10(1):1-14. doi: 10.4251/wjgo.v10.i1.1. Review.

4.

The colorectal cancer immune microenvironment and approach to immunotherapies.

Koi M, Carethers JM.

Future Oncol. 2017 Aug;13(18):1633-1647. doi: 10.2217/fon-2017-0145. Epub 2017 Aug 22. Review. No abstract available.

5.

Microsatellite Alterations With Allelic Loss at 9p24.2 Signify Less-Aggressive Colorectal Cancer Metastasis.

Koi M, Garcia M, Choi C, Kim HR, Koike J, Hemmi H, Nagasaka T, Okugawa Y, Toiyama Y, Kitajima T, Imaoka H, Kusunoki M, Chen YH, Mukherjee B, Boland CR, Carethers JM.

Gastroenterology. 2016 Apr;150(4):944-55. doi: 10.1053/j.gastro.2015.12.032. Epub 2016 Jan 2.

6.

EMAST is a Form of Microsatellite Instability That is Initiated by Inflammation and Modulates Colorectal Cancer Progression.

Carethers JM, Koi M, Tseng-Rogenski SS.

Genes (Basel). 2015 Mar 31;6(2):185-205. doi: 10.3390/genes6020185. Review.

7.

MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis.

Hur K, Toiyama Y, Takahashi M, Balaguer F, Nagasaka T, Koike J, Hemmi H, Koi M, Boland CR, Goel A.

Gut. 2013 Sep;62(9):1315-26. doi: 10.1136/gutjnl-2011-301846. Epub 2012 Jun 26.

8.

Association between recurrent metastasis from stage II and III primary colorectal tumors and moderate microsatellite instability.

Garcia M, Choi C, Kim HR, Daoud Y, Toiyama Y, Takahashi M, Goel A, Boland CR, Koi M.

Gastroenterology. 2012 Jul;143(1):48-50.e1. doi: 10.1053/j.gastro.2012.03.034. Epub 2012 Mar 27.

9.

Down-regulation of MutS homolog 3 by hypoxia in human colorectal cancer.

Li J, Koike J, Kugoh H, Arita M, Ohhira T, Kikuchi Y, Funahashi K, Takamatsu K, Boland CR, Koi M, Hemmi H.

Biochim Biophys Acta. 2012 Apr;1823(4):889-99. doi: 10.1016/j.bbamcr.2012.01.017. Epub 2012 Feb 9.

10.

MSH3 mediates sensitization of colorectal cancer cells to cisplatin, oxaliplatin, and a poly(ADP-ribose) polymerase inhibitor.

Takahashi M, Koi M, Balaguer F, Boland CR, Goel A.

J Biol Chem. 2011 Apr 8;286(14):12157-65. doi: 10.1074/jbc.M110.198804. Epub 2011 Feb 1.

11.

Tumor hypoxia and genetic alterations in sporadic cancers.

Koi M, Boland CR.

J Obstet Gynaecol Res. 2011 Feb;37(2):85-98. doi: 10.1111/j.1447-0756.2010.01377.x. Epub 2011 Jan 27. Review. No abstract available.

12.

De novo constitutional MLH1 epimutations confer early-onset colorectal cancer in two new sporadic Lynch syndrome cases, with derivation of the epimutation on the paternal allele in one.

Goel A, Nguyen TP, Leung HC, Nagasaka T, Rhees J, Hotchkiss E, Arnold M, Banerji P, Koi M, Kwok CT, Packham D, Lipton L, Boland CR, Ward RL, Hitchins MP.

Int J Cancer. 2011 Feb 15;128(4):869-78. doi: 10.1002/ijc.25422.

13.

Microsatellite instability at tetranucleotide repeats in sporadic colorectal cancer in Japan.

Yamada K, Kanazawa S, Koike J, Sugiyama H, Xu C, Funahashi K, Boland CR, Koi M, Hemmi H.

Oncol Rep. 2010 Feb;23(2):551-61.

14.

JC virus mediates invasion and migration in colorectal metastasis.

Link A, Shin SK, Nagasaka T, Balaguer F, Koi M, Jung B, Boland CR, Goel A.

PLoS One. 2009 Dec 3;4(12):e8146. doi: 10.1371/journal.pone.0008146.

15.

Analysis of fecal DNA methylation to detect gastrointestinal neoplasia.

Nagasaka T, Tanaka N, Cullings HM, Sun DS, Sasamoto H, Uchida T, Koi M, Nishida N, Naomoto Y, Boland CR, Matsubara N, Goel A.

J Natl Cancer Inst. 2009 Sep 16;101(18):1244-58. doi: 10.1093/jnci/djp265. Epub 2009 Aug 21.

16.

Genetic instability caused by loss of MutS homologue 3 in human colorectal cancer.

Haugen AC, Goel A, Yamada K, Marra G, Nguyen TP, Nagasaka T, Kanazawa S, Koike J, Kikuchi Y, Zhong X, Arita M, Shibuya K, Oshimura M, Hemmi H, Boland CR, Koi M.

Cancer Res. 2008 Oct 15;68(20):8465-72. doi: 10.1158/0008-5472.CAN-08-0002.

17.

Mutations in both KRAS and BRAF may contribute to the methylator phenotype in colon cancer.

Nagasaka T, Koi M, Kloor M, Gebert J, Vilkin A, Nishida N, Shin SK, Sasamoto H, Tanaka N, Matsubara N, Boland CR, Goel A.

Gastroenterology. 2008 Jun;134(7):1950-60, 1960.e1. doi: 10.1053/j.gastro.2008.02.094. Epub 2008 Mar 8.

18.
19.

Role of p21waf1/cip1 in effects of oxaliplatin in colorectal cancer cells.

Hata T, Yamamoto H, Ngan CY, Koi M, Takagi A, Damdinsuren B, Yasui M, Fujie Y, Matsuzaki T, Hemmi H, Xu X, Kitani K, Seki Y, Takemasa I, Ikeda M, Sekimoto M, Matsuura N, Monden M.

Mol Cancer Ther. 2005 Oct;4(10):1585-94.

20.

Microsatellite status and immunohistochemical features of ovarian clear-cell carcinoma.

Ueda H, Watanabe Y, Nakai H, Hemmi H, Koi M, Hoshiai H.

Anticancer Res. 2005 Jul-Aug;25(4):2785-8.

21.
22.

Hypersensitivity in DNA mismatch repair-deficient colon carcinoma cells to DNA polymerase reaction inhibitors.

Takahashi T, Min Z, Uchida I, Arita M, Watanabe Y, Koi M, Hemmi H.

Cancer Lett. 2005 Mar 18;220(1):85-93.

PMID:
15737691
23.

A change in microsatellite instability caused by cisplatin-based chemotherapy of ovarian cancer.

Watanabe Y, Koi M, Hemmi H, Hoshai H, Noda K.

Br J Cancer. 2001 Sep 28;85(7):1064-9.

24.
25.

Complementation of an hMSH2 defect in human colorectal carcinoma cells by human chromosome 2 transfer.

Watanabe Y, Haugen-Strano A, Umar A, Yamada K, Hemmi H, Kikuchi Y, Takano S, Shibata Y, Barrett JC, Kunkel TA, Koi M.

Mol Carcinog. 2000 Sep;29(1):37-49.

PMID:
11020245
26.

Complementation of mismatch repair gene defects by chromosome transfer.

Tindall KR, Glaab WE, Umar A, Risinger JI, Koi M, Barrett JC, Kunkel TA.

Mutat Res. 1998 Jun 18;402(1-2):15-22. Review.

PMID:
9675233
27.

Rescue of targeted regions of mammalian chromosomes by in vivo recombination in yeast.

Kouprina N, Kawamoto K, Barrett JC, Larionov V, Koi M.

Genome Res. 1998 Jun;8(6):666-72.

28.

Loss of heterozygosity at chromosome segment Xq25-26.1 in advanced human ovarian carcinomas.

Choi C, Cho S, Horikawa I, Berchuck A, Wang N, Cedrone E, Jhung SW, Lee JB, Kerr J, Chenevix-Trench G, Kim S, Barrett JC, Koi M.

Genes Chromosomes Cancer. 1997 Nov;20(3):234-42.

PMID:
9365830
29.

Correction of hypermutability, N-methyl-N'-nitro-N-nitrosoguanidine resistance, and defective DNA mismatch repair by introducing chromosome 2 into human tumor cells with mutations in MSH2 and MSH6.

Umar A, Koi M, Risinger JI, Glaab WE, Tindall KR, Kolodner RD, Boland CR, Barrett JC, Kunkel TA.

Cancer Res. 1997 Sep 15;57(18):3949-55.

30.

Undectable expression of hMLH1 protein in sporadic colorectal cancer with replication error phenotype.

Koike J, Yamada K, Takano S, Kikuchi Y, Hemmi H, Koi M, Tsujita K, Yanagita K, Yoshio T, Shimatake H.

Dis Colon Rectum. 1997 Oct;40(10 Suppl):S23-8.

PMID:
9378008
31.

Construction of chicken x human microcell hybrids for human gene targeting.

Koi M, Lamb PW, Filatov L, Feinberg AP, Barrett JC.

Cytogenet Cell Genet. 1997;76(1-2):72-6.

PMID:
9154132
32.

Competency in mismatch repair prohibits clonal expansion of cancer cells treated with N-methyl-N'-nitro-N-nitrosoguanidine.

Carethers JM, Hawn MT, Chauhan DP, Luce MC, Marra G, Koi M, Boland CR.

J Clin Invest. 1996 Jul 1;98(1):199-206.

33.

Loss of DNA mismatch repair in acquired resistance to cisplatin.

Aebi S, Kurdi-Haidar B, Gordon R, Cenni B, Zheng H, Fink D, Christen RD, Boland CR, Koi M, Fishel R, Howell SB.

Cancer Res. 1996 Jul 1;56(13):3087-90.

34.

Transcription-coupled repair deficiency and mutations in human mismatch repair genes.

Mellon I, Rajpal DK, Koi M, Boland CR, Champe GN.

Science. 1996 Apr 26;272(5261):557-60.

PMID:
8614807
35.

Evidence for a connection between the mismatch repair system and the G2 cell cycle checkpoint.

Hawn MT, Umar A, Carethers JM, Marra G, Kunkel TA, Boland CR, Koi M.

Cancer Res. 1995 Sep 1;55(17):3721-5.

36.

Human chromosome 3 corrects mismatch repair deficiency and microsatellite instability and reduces N-methyl-N'-nitro-N-nitrosoguanidine tolerance in colon tumor cells with homozygous hMLH1 mutation.

Koi M, Umar A, Chauhan DP, Cherian SP, Carethers JM, Kunkel TA, Boland CR.

Cancer Res. 1994 Aug 15;54(16):4308-12. Erratum in: Cancer Res 1995 Jan 1;55(1):201.

37.

Simple purification of human chromosomes to homogeneity using muntjac hybrid cells.

Lee JY, Koi M, Stanbridge EJ, Oshimura M, Kumamoto AT, Feinberg AP.

Nat Genet. 1994 May;7(1):29-33.

PMID:
8075635
38.

Tumor cell growth arrest caused by subchromosomal transferable DNA fragments from chromosome 11.

Koi M, Johnson LA, Kalikin LM, Little PF, Nakamura Y, Feinberg AP.

Science. 1993 Apr 16;260(5106):361-4.

PMID:
8469989
39.

Multiple tumor suppressor genes in multistep carcinogenesis.

Feinberg AP, Johnson LA, Law DJ, Kuehn SE, Steenman M, Williams BR, Thomas G, Boland CR, Rainier S, Koi M.

Tohoku J Exp Med. 1992 Oct;168(2):149-52.

40.
41.

Wilms tumor locus on 11p13 defined by multiple CpG island-associated transcripts.

Bonetta L, Kuehn SE, Huang A, Law DJ, Kalikin LM, Koi M, Reeve AE, Brownstein BH, Yeger H, Williams BR, et al.

Science. 1990 Nov 16;250(4983):994-7.

PMID:
2173146
42.

Transfer of a normal human chromosome 11 suppresses tumorigenicity of some but not all tumor cell lines.

Oshimura M, Kugoh H, Koi M, Shimizu M, Yamada H, Satoh H, Barrett JC.

J Cell Biochem. 1990 Mar;42(3):135-42.

PMID:
2318911
43.

Restoration of radiation resistance in ataxia telangiectasia cells by the introduction of normal human chromosome 11.

Komatsu K, Kodama S, Okumura Y, Koi M, Oshimura M.

Mutat Res. 1990 Mar;235(2):59-63.

PMID:
2155385
44.

Induction of cellular senescence in immortalized cells by human chromosome 1.

Sugawara O, Oshimura M, Koi M, Annab LA, Barrett JC.

Science. 1990 Feb 9;247(4943):707-10.

PMID:
2300822
45.

Role of a tumor-suppressor gene in the negative control of anchorage-independent growth of Syrian hamster cells.

Koi M, Afshari CA, Annab LA, Barrett JC.

Proc Natl Acad Sci U S A. 1989 Nov;86(22):8773-7.

46.
47.
48.

Normal human chromosome 11 suppresses tumorigenicity of human cervical tumor cell line SiHa.

Koi M, Morita H, Yamada H, Satoh H, Barrett JC, Oshimura M.

Mol Carcinog. 1989;2(1):12-21.

PMID:
2730761
49.

Role of chromosome loss in ras/myc-induced Syrian hamster tumors.

Oshimura M, Koi M, Ozawa N, Sugawara O, Lamb PW, Barrett JC.

Cancer Res. 1988 Mar 15;48(6):1623-32.

50.

Supplemental Content

Support Center